Skip to main content

Table 5 Results using the Enzygnost assays as compared to established EBV status

From: Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay

   

Enzygnost interpretation

 
  

Negative

Acute infection

Past infection

Indeterminate

% agreement with EBV status

EBV status

Negative (N = 39)

39

0

0

0

100

Acute infection (N = 15)

0

15

0

0

100

Past infection (N = 464)

2

2

460

0

99.1